Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

The cumulative incidence of National Institutes of Health (NIH)-defined chronic graft-versus-host disease (GVHD) requiring systemic treatment is ∼35% at 1 year after transplantation of granulocyte colony-stimulating factor (G-CSF)–mobilized blood cells from HLA-matched related or unrelated donors. W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Mielcarek, Marco, Furlong, Terry, O’Donnell, Paul V., Storer, Barry E., McCune, Jeannine S., Storb, Rainer, Carpenter, Paul A., Flowers, Mary E. D., Appelbaum, Frederick R., Martin, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2016
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4797026/
https://ncbi.nlm.nih.gov/pubmed/26764356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-10-672071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados